Kalocyte

Developer of a nanotechnology-based red blood cell substitute

placeSt. Louis, Missouri, United States calendar_todayFounded 2016 groups8 employees language kalocyte.com

Registered entities

Innovation

3 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 70 times.

YearFilings
20211
20222
20232
20242
20252
20261

Social engagement

Social engagement: 2.9K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Maryland Momentum Fund.

Investor typeCountShare
Venture capital778%
Accelerator & incubator111%
Other / undisclosed111%

Recent activity

20 Jun 2026
Event
BIO2026
17 Jun 2026
Leadership hire
Head of Analytical Process Development and CMC
Coming soon